Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Vitamin D metabolic pathway genes and pancreatic cancer risk.
Authors: Arem H,  Yu K,  Xiong X,  Moy K,  Freedman ND,  Mayne ST,  Albanes D,  Arslan AA,  Austin M,  Bamlet WR,  Beane-Freeman L,  Bracci P,  Canzian F,  Cotterchio M,  Duell EJ,  Gallinger S,  Giles GG,  Goggins M,  Goodman PJ,  Hartge P,  Hassan M,  Helzlsouer K,  Henderson B,  Holly EA,  Hoover R,  Jacobs EJ,  Kamineni A,  Klein A,  Klein E,  Kolonel LN,  Li D,  Malats N,  Männistö S,  McCullough ML,  Olson SH,  Orlow I,  Peters U,  Petersen GM,  Porta M,  Severi G,  Shu XO,  Visvanathan K,  White E,  Yu H,  Zeleniuch-Jacquotte A,  Zheng W,  Tobias GS,  Maeder D,  Brotzman M,  Risch H,  Sampson JN,  Stolzenberg-Solomon RZ
Journal: PLoS One
Date: 2015
Branches: BB, EBP, HGP, NEB
PubMed ID: 25799011
PMC ID: PMC4370655
Abstract: Evidence on the association between vitamin D status and pancreatic cancer risk is inconsistent. This inconsistency may be partially attributable to variation in vitamin D regulating genes. We selected 11 vitamin D-related genes (GC, DHCR7, CYP2R1, VDR, CYP27B1, CYP24A1, CYP27A1, RXRA, CRP2, CASR and CUBN) totaling 213 single nucleotide polymorphisms (SNPs), and examined associations with pancreatic adenocarcinoma. Our study included 3,583 pancreatic cancer cases and 7,053 controls from the genome-wide association studies of pancreatic cancer PanScans-I-III. We used the Adaptive Joint Test and the Adaptive Rank Truncated Product statistic for pathway and gene analyses, and unconditional logistic regression for SNP analyses, adjusting for age, sex, study and population stratification. We examined effect modification by circulating vitamin D concentration (≤50, >50 nmol/L) for the most significant SNPs using a subset of cohort cases (n = 713) and controls (n = 878). The vitamin D metabolic pathway was not associated with pancreatic cancer risk (p = 0.830). Of the individual genes, none were associated with pancreatic cancer risk at a significance level of p<0.05. SNPs near the VDR (rs2239186), LRP2 (rs4668123), CYP24A1 (rs2762932), GC (rs2282679), and CUBN (rs1810205) genes were the top SNPs associated with pancreatic cancer (p-values 0.008-0.037), but none were statistically significant after adjusting for multiple comparisons. Associations between these SNPs and pancreatic cancer were not modified by circulating concentrations of vitamin D. These findings do not support an association between vitamin D-related genes and pancreatic cancer risk. Future research should explore other pathways through which vitamin D status might be associated with pancreatic cancer risk.